We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App





New, Fast, Portable Saliva Screening Test Uses Infrared Light Technology to Confirm SARS-CoV-2 Infection

By LabMedica International staff writers
Posted on 31 May 2021
Print article
Image: This transmission electron microscope image shows SARS-CoV-2, also known as 2019-nCoV (Photo courtesy of NIAID)
Image: This transmission electron microscope image shows SARS-CoV-2, also known as 2019-nCoV (Photo courtesy of NIAID)
International research has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.

The new diagnostic approach involving the use of a portable infrared instrument to detect the SARS-CoV-2 virus in saliva, was led by scientists at Monash University (Melbourne, Australia) and the Peter Doherty Institute for Infection and Immunity (Melbourne, Australia) and could pave the way for safer and more efficient COVID-19 testing.

The team identified a signature of the infectious agent in the infrared spectra of saliva from 27 out of the 29 SARS-CoV-2-infected human subjects with COVID-19-like symptoms. The scientists say this is very encouraging preliminary research and are keen to see further testing with a larger patient cohort to better understand the specificity of this approach. A portable infrared spectrometer was modified to enable high throughput screening enabling the samples to be rapidly scanned in a contactless mode without having to clean the instrument between measurements.

The researchers estimate that this technique could be capable of screening 5000 samples per day per instrument, with results for each sample being ready in five minutes. Because the infrared light interacted with the vibrations of molecules, it could be used to generate a spectrum that represented a unique chemical fingerprint of the sample that was then processed using machine learning algorithms. The proposed new test also avoids the discomfort associated with nasopharyngeal swabs, an advantage that could improve community participation in testing.

A similar infrared technique known as Attenuated Total Reflectance (ATR) spectroscopy has previously been used by the Monash researchers to detect malaria and hepatitis. The new transflection infrared based approach offers triple the absorbance and hence interrogates more saliva to detect pathogens compared to the traditional ATR technology. The speed and versatility of the technique potentiates its use for point-of-care screening at airports, sporting venues, universities or schools, to triage patients for RT-PCR testing.

“The most significant advantages of using this infrared-based technology on saliva samples, include the speed and ease with which the test can be performed, its affordability and the reduced risk to both patients and healthcare workers,” said Professor Bayden Wood from the Monash University School of Chemistry.

“The approach has significant advantages over the standard Real Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) that is the current gold standard for detection,” said Professor Dale Godfrey from the Doherty Institute. “As we know, this requires that samples are sent to a dedicated laboratory and results take a day or more”.

“A person can contribute the sample by simply dribbling into a sterile container,” said Professor Damian Purcell from the Doherty Institute. “The result can be derived in less than five minutes and a rapid result minimizes the delay in determining if quarantine is required, therefore minimizing the risk of further spread of infection.”

Related Links:
Monash University
Peter Doherty Institute for Infection and Immunity


Gold Member
COVID-19 TEST READER
COVID-19-CHECK-1 EASY READER+
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Benchtop Cooler
PCR-Cooler & PCR-Rack

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.